Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus

Clinical trial NCT06729996 · RECRUITING

Trial details

NCT number: NCT06729996
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatitis, Chronic Pancreatitis, Acute Diabetes Mellitus

Start date: 2025-05-29
Primary completion: 2027-05-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.